Stifel Financial analysts downgraded Zoetis (ZTS) stock from a Buy to a Hold rating on Wednesday, citing slower growth over the next two years due to increased competition.
The animal health company’s shares fell by 4% on the news. Down nearly 8% over the past year, considerably worse than the 9.3% gain for the S&P 500 and 4.8% for Idexx Laboratories (IDXX), its biggest competitor.
